Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2022
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
1,240
-53.4%
|
$868,000
$700.0 P/Share
|
|
Mar 30
2022
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,240
+34.81%
|
$471,200
$380.95 P/Share
|
|
Mar 30
2022
|
P Roy Vagelos Director |
SELL
Open market or private sale
|
Indirect |
28,572
-23.98%
|
$20,000,400
$700.01 P/Share
|
|
Mar 30
2022
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
2,431
-28.56%
|
$1,701,700
$700.0 P/Share
|
|
Mar 30
2022
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,431
+22.21%
|
$909,194
$374.12 P/Share
|
|
Mar 30
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
408
-27.38%
|
$285,192
$699.0 P/Share
|
|
Mar 30
2022
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
408
+21.5%
|
$152,592
$374.12 P/Share
|
|
Mar 29
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
1,522
-58.45%
|
$1,063,878
$699.0 P/Share
|
|
Mar 29
2022
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,522
+36.89%
|
$569,228
$374.12 P/Share
|
|
Mar 29
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
2,683
-0.63%
|
$1,845,904
$688.04 P/Share
|
|
Mar 28
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,817
-7.16%
|
$8,094,645
$685.26 P/Share
|
|
Mar 28
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,500
+7.94%
|
$6,699,000
$462.06 P/Share
|
|
Mar 21
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
7,439
-76.63%
|
$5,132,910
$690.0 P/Share
|
|
Mar 21
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,439
+43.38%
|
$2,826,820
$380.95 P/Share
|
|
Mar 21
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-1.07%
|
$215,592
$691.31 P/Share
|
|
Mar 21
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.36%
|
$152,400
$381.92 P/Share
|
|
Mar 21
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
300
-1.04%
|
$207,900
$693.0 P/Share
|
|
Mar 17
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
7,830
-77.53%
|
$5,324,400
$680.0 P/Share
|
|
Mar 17
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+43.67%
|
$2,944,080
$376.69 P/Share
|
|
Mar 17
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
286
-0.98%
|
$195,052
$682.5 P/Share
|
|
Mar 17
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
365
+1.23%
|
$139,065
$381.92 P/Share
|
|
Mar 17
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
83
-0.29%
|
$56,938
$686.0 P/Share
|
|
Mar 16
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
4,361
-65.78%
|
$2,943,675
$675.0 P/Share
|
|
Mar 16
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,361
+39.68%
|
$1,631,014
$374.12 P/Share
|
|
Mar 16
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
300
-1.03%
|
$203,100
$677.0 P/Share
|
|
Mar 16
2022
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
2,000
-64.89%
|
$1,350,000
$675.0 P/Share
|
|
Mar 16
2022
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+39.35%
|
$782,000
$391.92 P/Share
|
|
Mar 14
2022
|
P Roy Vagelos Director |
SELL
Payment of exercise price or tax liability
|
Direct |
48,103
-12.22%
|
$31,507,465
$655.29 P/Share
|
|
Mar 14
2022
|
P Roy Vagelos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+16.0%
|
$13,425,000
$179.13 P/Share
|
|
Mar 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.84%
|
$615,000
$615.39 P/Share
|
|
Mar 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.62%
|
$342,000
$342.93 P/Share
|
|
Mar 01
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$61,500
$615.47 P/Share
|
|
Feb 28
2022
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.63%
|
$1,230,000
$615.5 P/Share
|
|
Feb 25
2022
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
2,000
-6.66%
|
$1,242,000
$621.0 P/Share
|
|
Feb 23
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Indirect |
500
-6.53%
|
$304,000
$608.68 P/Share
|
|
Feb 23
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Open market or private sale
|
Direct |
6,781
-1.8%
|
$4,149,972
$612.92 P/Share
|
|
Feb 22
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
33,219
-47.07%
|
$20,263,590
$610.56 P/Share
|
|
Feb 22
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+36.17%
|
$15,960,000
$399.66 P/Share
|
|
Feb 18
2022
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
335
-0.63%
|
-
|
|
Feb 15
2022
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
3,540
-0.53%
|
$2,226,660
$629.34 P/Share
|
|
Feb 14
2022
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
6,460
-9.43%
|
$4,043,960
$626.79 P/Share
|
|
Feb 14
2022
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.74%
|
$1,790,000
$179.13 P/Share
|
|
Feb 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.84%
|
$607,000
$607.46 P/Share
|
|
Feb 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.62%
|
$342,000
$342.93 P/Share
|
|
Feb 01
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$60,600
$606.04 P/Share
|
|
Jan 04
2022
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
338
-0.24%
|
-
|
|
Jan 03
2022
|
Michael S Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
191
+15.0%
|
-
|
|
Jan 03
2022
|
Joseph L Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
191
+3.04%
|
-
|
|
Jan 03
2022
|
George L Sing Director |
BUY
Grant, award, or other acquisition
|
Direct |
191
+0.63%
|
-
|
|
Jan 03
2022
|
Arthur F Ryan Director |
BUY
Grant, award, or other acquisition
|
Direct |
191
+0.84%
|
-
|